AR082270A1 - COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH - Google Patents

COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH

Info

Publication number
AR082270A1
AR082270A1 ARP110101876A AR082270A1 AR 082270 A1 AR082270 A1 AR 082270A1 AR P110101876 A ARP110101876 A AR P110101876A AR 082270 A1 AR082270 A1 AR 082270A1
Authority
AR
Argentina
Prior art keywords
composition
agents
weight
compositions
oral care
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Odete Tieko Yamane
Correa Fernanda Cristina Geraldo
Ramos Sandra Pereira
Da Costa Katrin Chaves
Enzo Toshio Utima
Prat Erico Vieira
Michael Prencipe
Richard Scott Robinson
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Priority to ARP110101876 priority Critical patent/AR082270A1/en
Publication of AR082270A1 publication Critical patent/AR082270A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones que impiden el crecimiento de las bacterias resistentes a altas concentraciones salinas, los métodos para su preparación y sus métodos de uso.Reivindicación 1: Una composición para el cuidado oral caracterizada porque incluye carbonato de calcio; alcohol bencílico; uno o más agentes de precipitación; y uno o más agentes depuradores de iones de calcio. Reivindicación 2: La composición de la reivindicación 1 caracterizada porque al menos uno de los uno o más agentes de precipitación es seleccionado a partir de silicato de sodio y pirofosfato tetrasódico. Reivindicación 3: La composición de la reivindicación 1, caracterizada porque al menos uno de los uno o más agentes depuradores de iones de calcio es seleccionado a partir de fosfato monosódico, hidrógeno fosfato disódico y bicarbonato de sodio. Reivindicación 6: La composición de la reivindicación 1, caracterizada porque además incluye uno o más agentes modificadores del pH. Reivindicación 8: La composición de la reivindicación 7, caracterizada porque al menos uno de los uno o más agentes modificadores del pH es hidróxido de sodio. Reivindicación 11: La composición de la reivindicación 1, caracterizada porque el pH se ubica entre aproximadamente 9 y alrededor de 10. Reivindicación 28: La composición de la reivindicación 27, caracterizada porque el sistema bacteriostático incluye entre aproximadamente 0,05% y alrededor de 2% en peso de pirofosfato tetrasódico; entre aproximadamente 0,05% y alrededor de 2% en peso de bicarbonato de sodio; entre aproximadamente 0,2% y alrededor de 0,5% en peso de alcohol bencílico; y entre aproximadamente 0,05% y alrededor de 0,2% en peso de hidróxido de sodio. Reivindicación 37: La composición de la reivindicación 1, caracterizada porque además incluye bicarbonato de L-arginina.Compositions that prevent the growth of bacteria resistant to high salt concentrations, the methods for their preparation and their methods of use. Claim 1: An oral care composition characterized in that it includes calcium carbonate; benzyl alcohol; one or more precipitation agents; and one or more calcium ion purifying agents. Claim 2: The composition of claim 1 characterized in that at least one of the one or more precipitating agents is selected from sodium silicate and tetrasodium pyrophosphate. Claim 3: The composition of claim 1, characterized in that at least one of the one or more calcium ion scavenging agents is selected from monosodium phosphate, disodium hydrogen phosphate and sodium bicarbonate. Claim 6: The composition of claim 1, characterized in that it also includes one or more pH modifying agents. Claim 8: The composition of claim 7, characterized in that at least one of the one or more pH modifying agents is sodium hydroxide. Claim 11: The composition of claim 1, characterized in that the pH is between about 9 and about 10. Claim 28: The composition of claim 27, characterized in that the bacteriostatic system includes between about 0.05% and about 2 % by weight of tetrasodium pyrophosphate; between about 0.05% and about 2% by weight of sodium bicarbonate; between about 0.2% and about 0.5% by weight of benzyl alcohol; and between about 0.05% and about 0.2% by weight of sodium hydroxide. Claim 37: The composition of claim 1, characterized in that it further includes L-arginine bicarbonate.

ARP110101876 2011-05-31 2011-05-31 COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH AR082270A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP110101876 AR082270A1 (en) 2011-05-31 2011-05-31 COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP110101876 AR082270A1 (en) 2011-05-31 2011-05-31 COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH

Publications (1)

Publication Number Publication Date
AR082270A1 true AR082270A1 (en) 2012-11-28

Family

ID=47562006

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101876 AR082270A1 (en) 2011-05-31 2011-05-31 COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH

Country Status (1)

Country Link
AR (1) AR082270A1 (en)

Similar Documents

Publication Publication Date Title
BR112012027179A2 (en) microbial growth resistant oral hygiene compositions
RS53994B1 (en) Micronized caco3 slurry injection system for the remineralization of desalinated and fresh water
ES2525721T3 (en) Composition that has biocidal activity for aqueous preparations
CY1118189T1 (en) ENLARGEMENT OF SALT WATER AND GLUT WATER BY ADMINISTRATION OF A SOIL CALCIUM SOLUTION IN SOFT WATER
CO6190603A2 (en) ACID 7- (2-METHYLPIRIDIN-3-IL CARBOMOIL) -4A-BENZIL-2- (TRIFLUOROMETIL) -1,2,3,4,4A, 9, 10, 10A-OCTAHIDRO FENANTREN-2-IL-2-PHOSPHONIC AS GLUCOCORTICOID RECEPTOR MODULATORS
RU2015126801A (en) FLUORIDE-STABLE ZINC-CONTAINING COMPOSITIONS FOR CARE OF THE ORAL CAVITY
CL2013003000A1 (en) Pharmaceutical composition for oral care, comprising a calcium salt and a source of soluble phosphate; method to whiten and remineralize teeth; and use of said composition in remineralization, decreased sensitivity and / or teeth whitening and combinations thereof.
CL2012000079A1 (en) Process for the reduction of magnesium in a brine, which comprises adjusting the brine to a lithium content of 4.5 to 6% by weight, adding kcl solution to precipitate carnalite, and further concentrating and precipitating magnesium as carnalite; lithium carbonate; and lithium chloride.
AR084863A1 (en) INHIBITORS OF GIRASA AND TOPOISOMERASE IV USEFUL TO TREAT BACTERIAL INFECTIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MX336343B (en) Compositions and methods for improving the compatibility of water soluble herbicide salts.
AR065963A1 (en) WATER SOLUTION OF HYDROGEN PEROXIDE, PROCESS FOR PREPARATION AND USE
BRPI0416360A (en) process for the cultivation of thraustochytriales microorganisms using a low-optimized medium
GT201400027A (en) Aqueous CONCENTRATED SUSPENSION THAT INCLUDES AN ACID DODECILGUANIDINE SALT
BR112013001743A2 (en) biocidal composition, and method for controlling growth of microorganisms in an aqueous or water-containing system.
BR112014000547A2 (en) deoxycholic acid formulations and salts thereof
BR112012026659A2 (en) surface disinfecting compound.
AR089269A1 (en) COMPOSITIONS FOR ORAL CARE
ES2509966T1 (en) Compositions having increased concentrations of carboxymethyl cellulose
AR088067A1 (en) METHOD FOR REDUCING TRANSPIRATION AND ANTITRANSPIRANT COMPOSITIONS
AR083443A1 (en) A COMPOSITION THAT INCLUDES BACTERIAL ARN AND BACTERIAL CELL WALLS, METHOD FOR PREPARING SUCH COMPOSITION AND ITS USES
AR084580A1 (en) ORAL LIQUID CARE COMPOSITIONS
BR112014012762A2 (en) reduced wound healing system
AR087371A1 (en) FORMULATIONS OF (TRIMETOXIFENILAMINO) PYRIMIDINYL, METHODS
PE20130374A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING IBUPROFEN
AR082270A1 (en) COMPOSITIONS FOR ORAL CARE RESISTANT TO MICROBIAL GROWTH

Legal Events

Date Code Title Description
FB Suspension of granting procedure